Literature DB >> 26016947

Hospitalization Type and Subsequent Severe Sepsis.

Hallie C Prescott1,2, Robert P Dickson1, Mary A M Rogers1,2, Kenneth M Langa1,2,3,4, Theodore J Iwashyna1,2,3,4.   

Abstract

RATIONALE: Hospitalization is associated with microbiome perturbation (dysbiosis), and this perturbation is more severe in patients treated with antimicrobials.
OBJECTIVES: To evaluate whether hospitalizations known to be associated with periods of microbiome perturbation are associated with increased risk of severe sepsis after hospital discharge.
METHODS: We studied participants in the U.S. Health and Retirement Study with linked Medicare claims (1998-2010). We measured whether three hospitalization types associated with increasing severity of probable dysbiosis (non-infection-related hospitalization, infection-related hospitalization, and hospitalization with Clostridium difficile infection [CDI]) were associated with increasing risk for severe sepsis in the 90 days after hospital discharge. We used two study designs: the first was a longitudinal design with between-person comparisons and the second was a self-controlled case series design using within-person comparison.
MEASUREMENTS AND MAIN RESULTS: We identified 43,095 hospitalizations among 10,996 Health and Retirement Study-Medicare participants. In the 90 days following non-infection-related hospitalization, infection-related hospitalization, and hospitalization with CDI, adjusted probabilities of subsequent admission for severe sepsis were 4.1% (95% confidence interval [CI], 3.8-4.4%), 7.1% (95% CI, 6.6-7.6%), and 10.7% (95% CI, 7.7-13.8%), respectively. The incidence rate ratio (IRR) of severe sepsis was 3.3-fold greater during the 90 days after hospitalizations than during other observation periods. The IRR was 30% greater after an infection-related hospitalization versus a non-infection-related hospitalization. The IRR was 70% greater after a hospitalization with CDI than an infection-related hospitalization without CDI.
CONCLUSIONS: There is a strong dose-response relationship between events known to result in dysbiosis and subsequent severe sepsis hospitalization that is not present for rehospitalization for nonsepsis diagnoses.

Entities:  

Keywords:  dysbiosis; humans; microbiota; patient readmission; self-controlled case series

Mesh:

Substances:

Year:  2015        PMID: 26016947      PMCID: PMC4595694          DOI: 10.1164/rccm.201503-0483OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  57 in total

1.  Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study.

Authors:  Susanne Mueller; Katiana Saunier; Christiana Hanisch; Elisabeth Norin; Livia Alm; Tore Midtvedt; Alberto Cresci; Stefania Silvi; Carla Orpianesi; Maria Cristina Verdenelli; Thomas Clavel; Corinna Koebnick; Hans-Joachim Franz Zunft; Joël Doré; Michael Blaut
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

Review 2.  The microbiome and rheumatoid arthritis.

Authors:  Jose U Scher; Steven B Abramson
Journal:  Nat Rev Rheumatol       Date:  2011-08-23       Impact factor: 20.543

Review 3.  Role of the gut microbiota in immunity and inflammatory disease.

Authors:  Nobuhiko Kamada; Sang-Uk Seo; Grace Y Chen; Gabriel Núñez
Journal:  Nat Rev Immunol       Date:  2013-05       Impact factor: 53.106

4.  Cohort Profile: the Health and Retirement Study (HRS).

Authors:  Amanda Sonnega; Jessica D Faul; Mary Beth Ofstedal; Kenneth M Langa; John W R Phillips; David R Weir
Journal:  Int J Epidemiol       Date:  2014-03-25       Impact factor: 7.196

5.  Use and misuse of the receiver operating characteristic curve in risk prediction.

Authors:  Nancy R Cook
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

Review 6.  Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis.

Authors:  Claudia Slimings; Thomas V Riley
Journal:  J Antimicrob Chemother       Date:  2013-12-08       Impact factor: 5.790

7.  Identifying patients with severe sepsis using administrative claims: patient-level validation of the angus implementation of the international consensus conference definition of severe sepsis.

Authors:  Theodore J Iwashyna; Andrew Odden; Jeffrey Rohde; Catherine Bonham; Latoya Kuhn; Preeti Malani; Lena Chen; Scott Flanders
Journal:  Med Care       Date:  2014-06       Impact factor: 2.983

8.  Elevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deaths.

Authors:  Sachin Yende; Gina D'Angelo; Florian Mayr; John A Kellum; Lisa Weissfeld; A Murat Kaynar; Tammy Young; Kaikobad Irani; Derek C Angus
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

9.  Gut microbiota disturbance during antibiotic therapy: a multi-omic approach.

Authors:  Ana Elena Pérez-Cobas; María José Gosalbes; Anette Friedrichs; Henrik Knecht; Alejandro Artacho; Kathleen Eismann; Wolfgang Otto; David Rojo; Rafael Bargiela; Martin von Bergen; Sven C Neulinger; Carolin Däumer; Femke-Anouska Heinsen; Amparo Latorre; Coral Barbas; Jana Seifert; Vitor Martins dos Santos; Stephan J Ott; Manuel Ferrer; Andrés Moya
Journal:  Gut       Date:  2012-12-12       Impact factor: 23.059

10.  Depression, antidepressant medications, and risk of Clostridium difficile infection.

Authors:  Mary A M Rogers; M Todd Greene; Vincent B Young; Sanjay Saint; Kenneth M Langa; John Y Kao; David M Aronoff
Journal:  BMC Med       Date:  2013-05-07       Impact factor: 8.775

View more
  62 in total

Review 1.  The microbiome and critical illness.

Authors:  Robert P Dickson
Journal:  Lancet Respir Med       Date:  2015-12-12       Impact factor: 30.700

2.  Paths into Sepsis: Trajectories of Presepsis Healthcare Use.

Authors:  Hallie C Prescott; Alicia G Carmichael; Kenneth M Langa; Richard Gonzalez; Theodore J Iwashyna
Journal:  Ann Am Thorac Soc       Date:  2019-01

3.  Toward a Nuanced Understanding of the Role of Infection in Readmissions After Sepsis.

Authors:  Hallie C Prescott
Journal:  Crit Care Med       Date:  2016-03       Impact factor: 7.598

4.  Risk of Subsequent Sepsis Within 90 Days After a Hospital Stay by Type of Antibiotic Exposure.

Authors:  James Baggs; John A Jernigan; Alison Laufer Halpin; Lauren Epstein; Kelly M Hatfield; L Clifford McDonald
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

5.  Readmission Diagnoses After Pediatric Severe Sepsis Hospitalization.

Authors:  Erin F Carlton; Joseph G Kohne; Manu Shankar-Hari; Hallie C Prescott
Journal:  Crit Care Med       Date:  2019-04       Impact factor: 7.598

6.  Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients.

Authors:  E R Dubberke; K A Reske; M A Olsen; K Bommarito; A A Cleveland; F P Silveira; M G Schuster; C A Kauffman; R K Avery; P G Pappas; T M Chiller
Journal:  Transpl Infect Dis       Date:  2018-03-06       Impact factor: 2.228

Review 7.  Improving Long-Term Outcomes After Sepsis.

Authors:  Hallie C Prescott; Deena Kelly Costa
Journal:  Crit Care Clin       Date:  2017-10-05       Impact factor: 3.598

Review 8.  The intestinal microbiome and surgical disease.

Authors:  Monika A Krezalek; Kinga B Skowron; Kristina L Guyton; Baddr Shakhsheer; Sanjiv Hyoju; John C Alverdy
Journal:  Curr Probl Surg       Date:  2016-06-14       Impact factor: 1.909

Review 9.  The immunopathology of sepsis and potential therapeutic targets.

Authors:  Tom van der Poll; Frank L van de Veerdonk; Brendon P Scicluna; Mihai G Netea
Journal:  Nat Rev Immunol       Date:  2017-04-24       Impact factor: 53.106

10.  All-Cause Hospitalizations after Large-Scale Hurricanes among Older Adults: A Self-Controlled Case Series Study.

Authors:  Sue Anne Bell; Theodore J Iwashyna; Xingyu Zhang; Bingxin Chen; Matthew A Davis
Journal:  Prehosp Disaster Med       Date:  2020-11-17       Impact factor: 2.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.